Skip to main content
Top
Published in: Pediatric Radiology 9/2018

01-08-2018 | Pediatric Body MRI

Hepatocyte-specific contrast media: not so simple

Authors: Andrew T. Trout, Alexander J. Towbin, Ethan A. Smith, Anita Gupta, Jonathan R. Dillman

Published in: Pediatric Radiology | Issue 9/2018

Login to get access

Abstract

Hepatocyte-specific contrast media are gadolinium chelates that are taken up by hepatocytes and partially cleared via the biliary tree. The absence of lesional uptake of the contrast media in the hepatobiliary phase is a marker of either the absence of hepatocytes or of poorly functioning, neoplastic hepatocytes. Uptake of the contrast media in the hepatobiliary phase, whether equal to or greater than background liver, reflects the presence of hepatocytes but does not equate to absence of neoplasia. Accurate diagnosis of liver lesions utilizing hepatocyte-specific contrast media requires an understanding of the mechanisms of uptake and clearance of the contrast media to avoid misdiagnosis. In this review we discuss the mechanisms of hepatocellular transport of hepatocyte-specific contrast media and utilize an understanding of those mechanisms to discuss the imaging appearance of a subset of hepatocellular lesions that can be seen in the pediatric and young adult liver. We pay particular attention to lesions that appear iso- to hyperintense in the hepatobiliary phase but have the potential for adverse clinical outcomes. We also discuss strategies for identifying these lesions.
Literature
1.
go back to reference Ringe KI, Husarik DB, Sirlin CB et al (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195:13–28CrossRefPubMed Ringe KI, Husarik DB, Sirlin CB et al (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195:13–28CrossRefPubMed
2.
go back to reference Burke C, Alexander Grant L, Goh V et al (2013) The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. Semin Ultrasound CT MR 34:44–53CrossRefPubMed Burke C, Alexander Grant L, Goh V et al (2013) The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. Semin Ultrasound CT MR 34:44–53CrossRefPubMed
3.
go back to reference Kolbe AB, Podberesky DJ, Zhang B et al (2015) The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion. Pediatr Radiol 45:354–365CrossRefPubMed Kolbe AB, Podberesky DJ, Zhang B et al (2015) The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion. Pediatr Radiol 45:354–365CrossRefPubMed
4.
go back to reference Chavhan GB, Mann E, Kamath BM et al (2014) Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children. Pediatr Radiol 44:1266–1274CrossRefPubMed Chavhan GB, Mann E, Kamath BM et al (2014) Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children. Pediatr Radiol 44:1266–1274CrossRefPubMed
5.
go back to reference Frydrychowicz A, Nagle SK, D'Souza SL et al (2011) Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid. J Magn Reson Imaging 34:585–594CrossRefPubMedPubMedCentral Frydrychowicz A, Nagle SK, D'Souza SL et al (2011) Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid. J Magn Reson Imaging 34:585–594CrossRefPubMedPubMedCentral
6.
7.
go back to reference Tsuboyama T, Onishi H, Kim T et al (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging — correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824–833CrossRefPubMed Tsuboyama T, Onishi H, Kim T et al (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging — correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824–833CrossRefPubMed
8.
go back to reference Yoneda N, Matsui O, Kitao A et al (2012) Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol 30:499–508CrossRefPubMed Yoneda N, Matsui O, Kitao A et al (2012) Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol 30:499–508CrossRefPubMed
9.
go back to reference International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993CrossRef International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993CrossRef
10.
go back to reference Grieser C, Steffen IG, Seehofer D et al (2013) Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics. Magn Reson Imaging 31:755–760CrossRefPubMed Grieser C, Steffen IG, Seehofer D et al (2013) Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics. Magn Reson Imaging 31:755–760CrossRefPubMed
11.
go back to reference Choi JY, Lee HC, Yim JH et al (2011) Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. J Gastroenterol Hepatol 26:1004–1009CrossRefPubMed Choi JY, Lee HC, Yim JH et al (2011) Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. J Gastroenterol Hepatol 26:1004–1009CrossRefPubMed
12.
go back to reference Quaglia A, Tibballs J, Grasso A et al (2003) Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 42:14–21CrossRefPubMed Quaglia A, Tibballs J, Grasso A et al (2003) Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 42:14–21CrossRefPubMed
13.
go back to reference Yoneda N, Matsui O, Kitao A et al (2016) Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background. Radiographics 36:2010–2027CrossRefPubMed Yoneda N, Matsui O, Kitao A et al (2016) Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background. Radiographics 36:2010–2027CrossRefPubMed
14.
go back to reference Chung EM, Lattin GE Jr, Cube R et al (2011) From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics 31:483–507CrossRefPubMed Chung EM, Lattin GE Jr, Cube R et al (2011) From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics 31:483–507CrossRefPubMed
15.
go back to reference Kitao A, Matsui O, Yoneda N et al (2011) The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 21:2056–2066CrossRefPubMed Kitao A, Matsui O, Yoneda N et al (2011) The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 21:2056–2066CrossRefPubMed
16.
go back to reference Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging — correlation with molecular transporters and histopathologic features. Radiology 256:817–826CrossRefPubMed Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging — correlation with molecular transporters and histopathologic features. Radiology 256:817–826CrossRefPubMed
17.
go back to reference Hope TA, Fowler KJ, Sirlin CB et al (2015) Hepatobiliary agents and their role in LI-RADS. Abdom Imaging 40:613–625CrossRefPubMed Hope TA, Fowler KJ, Sirlin CB et al (2015) Hepatobiliary agents and their role in LI-RADS. Abdom Imaging 40:613–625CrossRefPubMed
19.
go back to reference Katabathina VS, Menias CO, Shanbhogue AK et al (2011) Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics 31:1529–1543CrossRefPubMed Katabathina VS, Menias CO, Shanbhogue AK et al (2011) Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics 31:1529–1543CrossRefPubMed
20.
go back to reference Bioulac-Sage P, Sempoux C, Balabaud C (2017) Hepatocellular adenoma: classification, variants and clinical relevance. Semin Diagn Pathol 34:112–125CrossRefPubMed Bioulac-Sage P, Sempoux C, Balabaud C (2017) Hepatocellular adenoma: classification, variants and clinical relevance. Semin Diagn Pathol 34:112–125CrossRefPubMed
21.
go back to reference Thomeer MG, Willemssen FE, Biermann KK et al (2014) MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. J Magn Reson Imaging 39:1259–1264CrossRefPubMed Thomeer MG, Willemssen FE, Biermann KK et al (2014) MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. J Magn Reson Imaging 39:1259–1264CrossRefPubMed
22.
go back to reference McInnes MD, Hibbert RM, Inacio JR et al (2015) Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid-enhanced MR imaging — a systematic review. Radiology 277:413–423CrossRefPubMed McInnes MD, Hibbert RM, Inacio JR et al (2015) Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid-enhanced MR imaging — a systematic review. Radiology 277:413–423CrossRefPubMed
23.
go back to reference Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524CrossRefPubMed Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524CrossRefPubMed
24.
go back to reference Ba-Ssalamah A, Antunes C, Feier D et al (2015) Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Radiology 277:104–113CrossRefPubMed Ba-Ssalamah A, Antunes C, Feier D et al (2015) Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Radiology 277:104–113CrossRefPubMed
25.
go back to reference Agarwal S, Fuentes-Orrego JM, Arnason T et al (2014) Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol 203:W408–W414CrossRefPubMed Agarwal S, Fuentes-Orrego JM, Arnason T et al (2014) Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol 203:W408–W414CrossRefPubMed
26.
go back to reference Yoneda N, Matsui O, Kitao A et al (2012) Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol 30:777–782CrossRefPubMed Yoneda N, Matsui O, Kitao A et al (2012) Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol 30:777–782CrossRefPubMed
27.
go back to reference Kitao A, Matsui O, Yoneda N et al (2012) Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology 265:780–789CrossRefPubMedPubMedCentral Kitao A, Matsui O, Yoneda N et al (2012) Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology 265:780–789CrossRefPubMedPubMedCentral
28.
go back to reference Yoneda N, Matsui O, Kitao A et al (2013) Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature. Jpn J Radiol 31:480–490CrossRefPubMed Yoneda N, Matsui O, Kitao A et al (2013) Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature. Jpn J Radiol 31:480–490CrossRefPubMed
Metadata
Title
Hepatocyte-specific contrast media: not so simple
Authors
Andrew T. Trout
Alexander J. Towbin
Ethan A. Smith
Anita Gupta
Jonathan R. Dillman
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 9/2018
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-018-4108-x

Other articles of this Issue 9/2018

Pediatric Radiology 9/2018 Go to the issue